Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Mycobacterium w as Adjunct Therapy in Pulmonary Tuberculosis
NCT00341328Phase 3Completed
- Sponsor
- Ministry of Science and Technology
- Start
- Mar 2007
- Primary completion
- Oct 2011
- Modality
- Prophylactic Vaccines, Microbiome Therapeutics, Therapeutic Vaccines
- Countries
- 1
01
Overview
A Phase 3 trial of MYCIDAC-C in pulmonary tuberculosis (TB), sponsored by Ministry of Science and Technology. Started Mar 2007; status: completed.
02
Drugs
MYCIDAC-C
03
Conditions
pulmonary tuberculosis (TB)
Beyond the preview
Go deeper on NCT00341328.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT00341328.